对于晚期癌症老年患者的生活质量来说,补充黑素:一种随机对照试验
Angeline Ginzac1,2,3, Emmanuelle Bourbouloux4, Romain Rivoirard5
1INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, France. angeline.ginzac@clermont.unicancer.fr.
BMC geriatrics
|December 20, 2025
概括
黑素补充剂 (2毫克) 对老年癌症患者是安全的,但没有改善生活质量 (QoL). 在MEQAPAG试验中,在这个人群中没有发现显著的 QoL 益处.
科学领域:
- 老年瘤学 老年瘤学
- 药理学 药理学是指药理学的学科.
- 生活质量研究 研究 生命质量研究
背景情况:
- 在接受全身治疗的老年癌症患者 (≥70岁) 中,维持生活质量 (QoL) 是一个重大的临床挑战.
- 正在探索补充黑素作为一种潜在的策略,以减轻与治疗相关的副作用并改善幸福感.
研究的目的:
- 研究黑激素补充剂在改善接受全身治疗的老年癌症患者生活质量的有效性.
- 评估黑激素对睡眠的影响,尿中黑激素度,安全性和生存率.
主要方法:
- 进行了一项多中心,双盲,随机的安慰剂对照试验 (MEQAPAG).
- 在全身治疗的初始阶段,患者每天接受2毫克的黑激素90天.
- 生活质量主要是使用EORTC生活质量问卷核心30 (QLQ-C30) 进行评估.
主要成果:
- 该研究包括123名患者,其中59人被认为符合规定并可评估.
- 在黑激素和安慰剂组之间没有观察到总体QLQ-C30得分的统计学上显著差异.
- 在补充剂后的实验组中测量了尿液中的aMT6s度.
结论:
- 两毫克的黑激素补充剂对老年癌症患者来说是安全的,但并没有显著提高QLQ-C30测量的总体生活质量.
- 该MEQAPAG试验提供了有关老年癌症患者尿道aMT6s度的新数据.
相关概念视频
Management of Insomnia
499
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
499
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181
Sedatives and Hypnotics Drugs: Miscellaneous Agents
477
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
477
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
208
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
208
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
215
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
215


